Epic Research is a leading financial services provider with presence in Indian and other global capital markets. Provides Stock Tips, Forex Tips, Commodity Tips, MCX Tips, Equity Tips, Tips, Intraday Tips, NSE Tips, BSE Tips, COMEX Tips, PCG Pack and NCDEX Tips. We provide services in equity, commodity and Forex market.

1. 24TH December 2012
DAILY CHARTIST
VIEW

2. HIGHLIGHTS
A
 Highlights
 Nifty was highly bearish on Friday
 Nifty Future ended 79.95 points down at 5851.20
 We recommended two buy calls yesterday.
 Auro Pharma buy call hit 1st target and Bharti Airtel
remained unexecuted.
 Investors’ are advised to exit from these calls and take
position in the fresh calls provided below
 Sell Ambuja future below 199 for targets 196/192
 Buy BHEL futures above 241 for targets 249/260
 Past Performance:
 Auro Pharma buy call hit 1st target.
 JSW Steel buy call hit both targets.
 Allahabad bank sell call hit both targets.
 Voltas hit both targets
 Adani Enterprise hit target.
 Lupin almost hit 2nd target.
 Bata India hit both targets
 Havells sell call hit both targets.

3. AMBUJA FUTURES – DOUBLE TOP
SELL AMBUJA FUTURES BELOW 199 FOR TARGETS 196/192 SL 202
BUY ABOVE 250 FOR TARGETS OF 265/285 SL 235
 Sell Ambuja futures below 199
 Ambuja is making Double top on daily chart
 Currently trading at 200.10
 Break out will come below 200 but investors are advised
to sell only below 199
 SL is recommended at 202

4. BHEL FUTURE- TRIPLE BOTTOM
BUY AB0VE 241 FOR TARGETS 249/260 SL 234
 Buy BHEL Future above 241
 BHEL is making triple bottom on daily chart.
 Currently trading at 227.90
 We can expect breakout above 240 and investors’ can
buy above 241.
 Stop loss is recommended at 234.
 This call may take some time in execution.

5. Disclaimer
The information and view in this report, our website & all the service we provide
are believed to be reliable, but we do not accept any responsibility (or liability) for
errors of fact or opinion. Users have the right to choose the product/s that suits
them the most.
Sincere efforts have been made to present the right investment perspective. The
information contained herein is based on analysis and up on sources that we
consider reliable.
This material is for personal information and based upon it & takes no
responsibility
The information given herein should be treated as only factor, while making
investment decision. The report does not provide individually tailor-made
investment advice. Epic research recommends that investors independently
evaluate particular investments and strategies, and encourages investors to seek
the advice of a financial adviser. Epic research shall not be responsible for any
transaction conducted based on the information given in this report, which is in
violation of rules and regulations of NSE and BSE.
The share price projections shown are not necessarily indicative of future price
performance. The information herein, together with all estimates and forecasts, can
change without notice. Analyst or any person related to epic research might be
holding positions in the stocks recommended. It is understood that anyone who is
browsing through the site has done so at his free will and does not read any views
expressed as a recommendation for which either the site or its owners or
anyone can be held responsible for . Any surfing and reading of the information is
the acceptance of this disclaimer.
All Rights Reserved. Investment in equity & bullion market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. we are not
responsible for any loss incurred whatsoever for any financial profits or loss
which may arise from the recommendations above epic research does not purport
to be an invitation or an offer to buy or sell any financial instrument. Our Clients
(Paid Or Unpaid), Any third party or anyone else have no rights to forward or
share our calls or SMS or Report or Any other information provided by us to/with
anyone which is related directly or indirectly with them. If found so, then Serious
Legal Actions can be taken.